The question has shifted from "is it too expensive to cover GLP-1?" to "is it too expensive not to?" As clinical data accumulates showing that GLP-1 medications reduce the incidence and severity of the most expensive chronic diseases, payers are recognizing that proactive treatment of obesity saves money compared to treating its downstream consequences
Unintentional weight loss beyond your treatment goals requires assessment
Gastrointestinal symptoms beyond nausea are also common and may include: Decreased appetite or early satiety Mild abdominal discomfort or bloating Diarrhea (reported in 8-9% of Ozempic patients
Commonly worked with for 46 weeks at 28 C
Change spots by switching between your abdomen, thighs, and upper arms using a planned rotation
doi:10.1161/CIRCULATIONAHA.122.059595 McGough M, Lo J, Tevis D, Rae M, Cox C